Abbott (ABT) Receives FDA's Breakthrough Device Designation For Exploring Deep Brain Stimulation To Manage Severe DepressionPulse2 • 07/12/22
Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe DepressionPRNewsWire • 07/12/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/06/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/05/22
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/01/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmBusiness Wire • 06/30/22